{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T05:58:48Z","timestamp":1776923928782,"version":"3.51.2"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T00:00:00Z","timestamp":1736121600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Diagnostic Pathology"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.anndiagpath.2024.152434","type":"journal-article","created":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T07:38:59Z","timestamp":1736149139000},"page":"152434","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Nuclear pseudoinclusion is associated with BRAFV600E mutation: Analysis of nuclear features in papillary thyroid carcinoma"],"prefix":"10.1016","volume":"75","author":[{"given":"Agnes Stephanie","family":"Harahap","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dina","family":"Khoirunnisa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Salinah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Francisca","family":"Ham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.anndiagpath.2024.152434_bb0005","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1158\/1055-9965.EPI-21-1440","article-title":"Epidemiology of thyroid cancer","volume":"31","author":"Kitahara","year":"2022","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.anndiagpath.2024.152434_bb0010","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.cell.2014.09.050","article-title":"Integrated genomic characterization of papillary thyroid carcinoma","volume":"159","author":"Cancer Genome Atlas Research Network","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.anndiagpath.2024.152434_bb0015","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.21037\/gs-20-430","article-title":"Prevalence of BRAFV600E mutation in Asian series of papillary thyroid carcinoma-a contemporary systematic review","volume":"9","author":"Rashid","year":"2020","journal-title":"Gland Surg"},{"key":"10.1016\/j.anndiagpath.2024.152434_bb0020","doi-asserted-by":"crossref","first-page":"99","DOI":"10.2147\/TACG.S412364","article-title":"Profile of BRAFV600E, BRAFK601E, NRAS, HRAS, and KRAS mutational status, and clinicopathological characteristics of papillary thyroid carcinoma in Indonesian national referral hospital. Appl","volume":"16","author":"Harahap","year":"2023","journal-title":"Clin Genet"},{"key":"10.1016\/j.anndiagpath.2024.152434_bb0025","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s13000-019-0849-6","article-title":"Relevance and clinicopathologic relationship of BRAF V600E, TERT and NRAS mutations for papillary thyroid carcinoma patients in Northwest China","volume":"14","author":"Huang","year":"2019","journal-title":"Diagn Pathol"},{"key":"10.1016\/j.anndiagpath.2024.152434_bb0030","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1016\/j.humpath.2014.03.010","article-title":"Molecular testing for oncogenic gene mutations in thyroid lesions: a case-control validation study in 413 postsurgical specimens","volume":"45","author":"Giordano","year":"2014","journal-title":"Hum Pathol"},{"key":"10.1016\/j.anndiagpath.2024.152434_bb0035","doi-asserted-by":"crossref","first-page":"445","DOI":"10.3803\/EnM.2023.1702","article-title":"Different molecular phenotypes of progression in BRAF- and RAS-like papillary thyroid carcinoma","volume":"38","author":"Lim","year":"2023","journal-title":"Endocrinol Metab (Seoul)"},{"key":"10.1016\/j.anndiagpath.2024.152434_bb0040","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.eprac.2020.09.003","article-title":"Pathologic features associated with molecular subtypes of well-differentiated thyroid cancer","volume":"27","author":"Tang","year":"2021","journal-title":"Endocr Pract"},{"key":"10.1016\/j.anndiagpath.2024.152434_bb0045","unstructured":"Baloch ZW, Mete O, Fadda G, Kakudo K, Kondo T, LiVolsi V, et al. Papillary thyroid carcinoma. In: WHO Classification of Tumours Editorial Board. Endocrine and neuroendocrine tumors [Internet]. Lyon (France): International Agency for Research on Cancer; 2022 [cited 2024 Nov 24]. (WHO classification of tumours series, 5th ed.; vol. 10). Available from: https:\/\/tumourclassification.iarc.who.int\/chapters\/53."},{"key":"10.1016\/j.anndiagpath.2024.152434_bb0050","doi-asserted-by":"crossref","first-page":"123","DOI":"10.3803\/EnM.2020.860","article-title":"Molecular correlates and nuclear features of encapsulated follicular-patterned thyroid neoplasms","volume":"36","author":"Jung","year":"2021","journal-title":"Endocrinol Metab (Seoul)"},{"key":"10.1016\/j.anndiagpath.2024.152434_bb0055","series-title":"Thyroid FNA cytology","first-page":"173","article-title":"Nuclear features of papillary thyroid carcinoma (BRAF-like tumors), noninvasive follicular thyroid neoplasm with papillary-like nuclear features (RAS-like tumors), and follicular adenoma\/follicular thyroid carcinoma (RAS-like tumors)","author":"Kakudo","year":"2019"},{"key":"10.1016\/j.anndiagpath.2024.152434_bb0060","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1111\/j.1365-2559.2011.04149.x","article-title":"Papillary thyroid carcinomas with and without BRAF V600E mutations are morphologically distinct","volume":"60","author":"Finkelstein","year":"2012","journal-title":"Histopathology"},{"key":"10.1016\/j.anndiagpath.2024.152434_bb0065","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1186\/s12885-020-07636-0","article-title":"The age threshold of the 8th edition AJCC classification is useful for indicating patients with aggressive papillary thyroid cancer in clinical practice","volume":"20","author":"Kaliszewski","year":"2020","journal-title":"BMC Cancer"},{"key":"10.1016\/j.anndiagpath.2024.152434_bb0070","doi-asserted-by":"crossref","first-page":"499","DOI":"10.4158\/EP-2019-0385","article-title":"Tumor size is an independent predictor of mortality risk in differentiated thyroid cancer patients with T4 disease","volume":"26","author":"Wang","year":"2020","journal-title":"Endocr Pract"},{"key":"10.1016\/j.anndiagpath.2024.152434_bb0075","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s42047-024-00157-1","article-title":"Predictive biomarkers in thyroid cancer in the current molecular-morphology paradigm","volume":"7","author":"Carneiro","year":"2024","journal-title":"Surg Exp Pathol"},{"key":"10.1016\/j.anndiagpath.2024.152434_bb0080","doi-asserted-by":"crossref","first-page":"265","DOI":"10.4132\/jptm.2024.10.11","article-title":"Cytologic hallmarks and differential diagnosis of papillary thyroid carcinoma subtypes","volume":"58","author":"Harahap","year":"2024","journal-title":"J Pathol Transl Med"},{"key":"10.1016\/j.anndiagpath.2024.152434_bb0085","doi-asserted-by":"crossref","first-page":"9397755","DOI":"10.1155\/2023\/9397755","article-title":"The accurate interpretation and clinical significance of morphological features of fine needle aspiration cells in papillary thyroid carcinoma","volume":"1","author":"Xiong","year":"2023","journal-title":"Anal Cell Pathol (Amst)"},{"key":"10.1016\/j.anndiagpath.2024.152434_bb0090","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s13044-023-00161-9","article-title":"A study to evaluate association of nuclear grooving in benign thyroid lesions with RET\/PTC1 and RET\/PTC3 gene translocation","volume":"16","author":"Ashwini","year":"2023","journal-title":"Thyroid Res"},{"key":"10.1016\/j.anndiagpath.2024.152434_bb0095","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/S0002-9440(10)63468-2","article-title":"Nuclear envelope irregularity is induced by RET\/PTC during interphase","volume":"163","author":"Fischer","year":"2003","journal-title":"Am J Pathol"},{"key":"10.1016\/j.anndiagpath.2024.152434_bb0100","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1002\/cncy.22522","article-title":"NTRK-rearranged papillary thyroid carcinoma demonstrates frequent subtle nuclear features and indeterminate cytologic diagnoses","volume":"130","author":"Lee","year":"2022","journal-title":"Cancer Cytopathol"},{"key":"10.1016\/j.anndiagpath.2024.152434_bb0105","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1002\/(SICI)1097-4644(19980701)70:1<130::AID-JCB13>3.0.CO;2-T","article-title":"Ras-associated nuclear structural change appears functionally significant and independent of the mitotic signaling pathway","volume":"70","author":"Fischer","year":"1998","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.anndiagpath.2024.152434_bb0110","first-page":"1623","article-title":"The clinicopathological features of adult thyroid tumors with DICER1 mutation","volume":"104","author":"Tang","year":"2024","journal-title":"Chin Med J"},{"key":"10.1016\/j.anndiagpath.2024.152434_bb0115","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1385\/EP:13:4:289","article-title":"Etiology and significance of the optically clear nucleus","volume":"13","author":"Baloch","year":"2002","journal-title":"Endocr Pathol"},{"key":"10.1016\/j.anndiagpath.2024.152434_bb0120","doi-asserted-by":"crossref","first-page":"299","DOI":"10.4132\/jptm.2024.07.25","article-title":"Diagnostic challenges in the assessment of thyroid neoplasms using nuclear features and vascular and capsular invasion: a multi-center interobserver agreement study","volume":"58","author":"Harahap","year":"2024","journal-title":"J Pathol Transl Med"},{"key":"10.1016\/j.anndiagpath.2024.152434_bb0125","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1007\/s12022-018-9520-0","article-title":"An international interobserver variability reporting of the nuclear scoring criteria to diagnose noninvasive follicular thyroid neoplasm with papillary-like nuclear features: a validation study","volume":"29","author":"Thompson","year":"2018","journal-title":"Endocr Pathol"},{"key":"10.1016\/j.anndiagpath.2024.152434_bb0130","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/pin.12779","article-title":"Interobserver and intraobserver variation in the morphological evaluation of noninvasive follicular thyroid neoplasm with papillary-like nuclear features in Asian practice","volume":"69","author":"Liu","year":"2019","journal-title":"Pathol Int"},{"key":"10.1016\/j.anndiagpath.2024.152434_bb0135","doi-asserted-by":"crossref","first-page":"812","DOI":"10.3390\/cancers14030812","article-title":"Different threshold of malignancy for RAS-like thyroid tumors causes significant differences in thyroid nodule practice","volume":"14","author":"Kakudo","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.anndiagpath.2024.152434_bb0140","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1007\/s12022-022-09747-9","article-title":"The presence of typical \u201cBRAFV600E-like\u201d atypia in papillary thyroid carcinoma is highly specific for the presence of the BRAFV600E mutation","volume":"34","author":"Turchini","year":"2023","journal-title":"Endocr Pathol"}],"container-title":["Annals of Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1092913424001710?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1092913424001710?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T01:38:00Z","timestamp":1739497080000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1092913424001710"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":28,"alternative-id":["S1092913424001710"],"URL":"https:\/\/doi.org\/10.1016\/j.anndiagpath.2024.152434","relation":{},"ISSN":["1092-9134"],"issn-type":[{"value":"1092-9134","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nuclear pseudoinclusion is associated with BRAFV600E mutation: Analysis of nuclear features in papillary thyroid carcinoma","name":"articletitle","label":"Article Title"},{"value":"Annals of Diagnostic Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anndiagpath.2024.152434","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"152434"}}